Population
Plasma and platelets from healthy volunteers and patients previously treated with streptokinase for acute…
Design
Preclinical
Authors
Loading...
Animal data implicate Fc-FcγRII interaction in SK platelet effects; hypothesis-generating for human relevance and interventions.
Streptokinase modifies platelet aggregation through two distinct mechanisms: inhibition via fibrinogen degradation and enhancement via an immunological reaction involving anti-SK antibodies and platelet FcyRII receptors.
Abdelouahed et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: